CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 173 filers reported holding CONMED CORP in Q1 2014. The put-call ratio across all filers is 1.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $50,627,616 | -18.0% | 730,380 | -5.3% | 0.01% | -23.5% |
Q1 2024 | $61,740,239 | -20.9% | 770,982 | +8.2% | 0.02% | -26.1% |
Q4 2023 | $78,010,038 | +14.0% | 712,332 | +5.0% | 0.02% | +4.5% |
Q3 2023 | $68,432,004 | -25.2% | 678,538 | +0.8% | 0.02% | -24.1% |
Q2 2023 | $91,498,744 | +34.8% | 673,320 | +3.0% | 0.03% | +26.1% |
Q1 2023 | $67,883,305 | +119687.0% | 653,610 | +2.2% | 0.02% | +35.3% |
Q4 2022 | $56,670 | -99.9% | 639,318 | -0.2% | 0.02% | -15.0% |
Q3 2022 | $51,356,000 | -13.4% | 640,570 | +3.4% | 0.02% | -4.8% |
Q2 2022 | $59,336,000 | -38.2% | 619,614 | -4.1% | 0.02% | -30.0% |
Q1 2022 | $95,959,000 | -2.1% | 645,962 | -6.6% | 0.03% | 0.0% |
Q4 2021 | $98,017,000 | -0.9% | 691,417 | -8.6% | 0.03% | -6.2% |
Q3 2021 | $98,933,000 | -5.5% | 756,181 | -0.8% | 0.03% | -3.0% |
Q2 2021 | $104,727,000 | -0.8% | 762,041 | -5.7% | 0.03% | -5.7% |
Q1 2021 | $105,549,000 | -2.2% | 808,248 | -16.1% | 0.04% | -10.3% |
Q4 2020 | $107,938,000 | +34.6% | 963,731 | -5.5% | 0.04% | +14.7% |
Q3 2020 | $80,187,000 | +3.5% | 1,019,315 | -5.3% | 0.03% | 0.0% |
Q2 2020 | $77,508,000 | +21.3% | 1,076,690 | -3.5% | 0.03% | +3.0% |
Q1 2020 | $63,924,000 | -55.5% | 1,116,237 | -13.1% | 0.03% | -36.5% |
Q4 2019 | $143,673,000 | +9.8% | 1,284,761 | -5.6% | 0.05% | +2.0% |
Q3 2019 | $130,856,000 | +11.0% | 1,360,954 | -1.2% | 0.05% | +10.9% |
Q2 2019 | $117,908,000 | -5.3% | 1,377,908 | -7.9% | 0.05% | -8.0% |
Q1 2019 | $124,449,000 | +18.2% | 1,496,159 | -8.8% | 0.05% | +4.2% |
Q4 2018 | $105,291,000 | -24.3% | 1,640,062 | -6.6% | 0.05% | -9.4% |
Q3 2018 | $139,068,000 | +0.8% | 1,755,465 | -6.8% | 0.05% | -3.6% |
Q2 2018 | $137,925,000 | +5.0% | 1,884,217 | -9.2% | 0.06% | 0.0% |
Q1 2018 | $131,356,000 | +20.0% | 2,074,151 | -3.4% | 0.06% | +22.2% |
Q4 2017 | $109,441,000 | -6.4% | 2,147,161 | -3.7% | 0.04% | -11.8% |
Q3 2017 | $116,971,000 | +1.4% | 2,229,291 | -1.5% | 0.05% | -3.8% |
Q2 2017 | $115,329,000 | +10.8% | 2,264,021 | -3.4% | 0.05% | +6.0% |
Q1 2017 | $104,074,000 | +0.3% | 2,343,486 | -0.2% | 0.05% | -3.8% |
Q4 2016 | $103,744,000 | +9.6% | 2,348,741 | -0.6% | 0.05% | +2.0% |
Q3 2016 | $94,666,000 | -15.6% | 2,363,114 | +0.5% | 0.05% | -21.5% |
Q2 2016 | $112,193,000 | +15.7% | 2,350,620 | +1.7% | 0.06% | +12.1% |
Q1 2016 | $96,965,000 | -5.7% | 2,312,025 | -1.0% | 0.06% | -9.4% |
Q4 2015 | $102,862,000 | -6.9% | 2,335,120 | +0.9% | 0.06% | -12.3% |
Q3 2015 | $110,514,000 | -19.1% | 2,314,916 | -1.3% | 0.07% | -13.1% |
Q2 2015 | $136,636,000 | +15.7% | 2,344,877 | +0.3% | 0.08% | +12.0% |
Q1 2015 | $118,061,000 | +13.0% | 2,338,308 | +0.6% | 0.08% | +8.7% |
Q4 2014 | $104,475,000 | +20.7% | 2,323,731 | -1.1% | 0.07% | +13.1% |
Q3 2014 | $86,583,000 | -17.6% | 2,350,199 | -1.3% | 0.06% | -16.4% |
Q2 2014 | $105,117,000 | +2.7% | 2,380,926 | +1.1% | 0.07% | -3.9% |
Q1 2014 | $102,327,000 | -0.4% | 2,355,067 | -2.6% | 0.08% | -5.0% |
Q4 2013 | $102,779,000 | +27.2% | 2,418,335 | +1.8% | 0.08% | +14.3% |
Q3 2013 | $80,772,000 | +8.1% | 2,376,386 | -0.6% | 0.07% | 0.0% |
Q2 2013 | $74,719,000 | – | 2,391,789 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |